Looking forward joining discussion with great faculty colleagues at the PER symposium on experts addressing burning questions in DLBCL at ASCO in Chicago on June 2! Sign up today! bit.ly/3MMyTqS #HemOnc #gotoPER

Join us for the ASH|FDA Collaboration: A Workshop on Regulatory Science in Hematology to gain a deeper understanding of the U.S. FDA’s role in #hematology 🩸 Learn about product development, clinical trial design, & more! Apply now: loom.ly/lvtrMmQ

The Polish connection ⁦Greg⁩

Great to join FDA Oncology, AACR, ASA for today's workshop on Overall Survival in cancer clinical trials Nice introduction from FDA Oncology's Dr Gormley on different endpoint considerations & nuances of interpreting OS #AACRSciencePolicy Tatiana Prowell, MD

An ASCO task force paper published today in ACS Journal Cancer details 3 calls-to-action for the oncology research and care communities that could expand access to clinical trials and enable patients to participate closer to home. Learn more: brnw.ch/21wFVie #OncTwitter

PhD thesis today Côme Bommier discussing about MZL, surrogacy, endpoints. Strong collaboration with Mayo Clinic, Congratulations !

Lots of great connections happening at #ASCO24 (mainly thanks to this pin). Stop by and say 👋 to Dr. Greg and our experts at Mayo Clinic booth no. 27104!

Grzegorz S. Nowakowski, MD, discusses the accelerated approval of epcoritamab in follicular lymphoma, touching on key trial data and remaining unmet needs. Greg Mayo Clinic #lymsm #oncology #MedTwitter onclive.com/view/epcoritam…

100 years of Hematology Mayo Clinic Rochester, MN Hematology Division Faculty Mayo Clinic Comprehensive Cancer Center

Dinner with ⁦Greg⁩ and my excellent junior colleagues after great Gregg’ s talk and discussion in ⁦Univerzita Karlova⁩ Gen Hospital

Honored to be on the ballot for the Designated Community Oncology seat. ASCO has done a remarkable job of selecting a lineup of brilliant candidates. I personally have SO MUCH respect for each one of them! Your voice counts, please vote. asco.org/election ASCO Eric J. Small, MD, FASCO

Great discussion on the present and future of oncology drug development with Dr. Rick Pazdur - Distinguished Lecturer at MCCCC. Rick Pazdur Mayo Clinic Comprehensive Cancer Center U.S. FDA

I’m honored to be on the ballot for the ASCO Board of Directors with all the other amazing candidates. Learn more and 🗳️ ⬇️

We are seeking a lymphoma investigator to join our Lymphoid Malignancies Disease Group at Mayo Clinic in Rochester, MN. Join Greg, Steve Ansell, Witzig Laboratory and may other talented individuals to advance lymphoma care and research. jobs.mayoclinic.org/job/rochester/…

Thank you Mayo Clinic for recognizing Dr. Lee Greenberger, our SVP & Chief Scientific Officer of 11 years, for his service in the #BloodCancer space and collaboration in IMPACT grants last night. #ASH24 🔬🩸

Late-breaking abstract featured at #ASCO25: Mayo Clinic researchers found the addition of #immunotherapy to chemotherapy can reduce the recurrence and spread of #ColonCancer in patients with deficient DNA mismatch repair (dMMR). Learn more: newsnetwork.mayoclinic.org/discussion/imm… Frank Sinicrope, MD

Dr Ansell discussing plenary abstract ICML Lugano on predicting response to CART by microenvironment signature Mayo Clinic Comprehensive Cancer Center

Pola-R-CHP the new SOC for ALL DLBCL? Soni Smith MD YES vs. Greg NO Pola-R-CHP, RCHOP Some need Pola-R-CHP Some don't have access to Pola Some will be fine with RCHOP International Conference on Malignant Lymphoma #18ICML #lymsm

CONGRESS | #18ICML | PRESENTATION Patrick B Johnston, Mayo Clinic highlights results from the phase II DAILY II US trial of zamtocabtagene autoleucel in patients with R/R CNSL (N = 16). Zamto-cel was well tolerated in patients with R/R CNSL, with encouraging efficacy (ORR,

Right in time! Nice paper of 🇮🇹🇨🇿🇨🇭🇺🇸centers out! Primary Extranodal Follicular Lymphoma: A Retrospective Survey of the International Extranodal Lymphoma Study Group (IELSG) ⁦Stefano Luminari, MD⁩ ⁦Greg⁩ ⁦Marek Trneny⁩ onlinelibrary.wiley.com/doi/epdf/10.10…